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Abstract
Background
Influenza is an important cause of acute lower respiratory tract infection (aLRTI), hospitali-
zation, and mortality in children. This study aimed to describe the clinical and epidemiologic
patterns and infection factors associated with influenza, and compare case features of influ-
enza A and B.
Methods
In a prospective, cross-sectional study, patients admitted for aLRTI, between 2000 and
2015, were tested for respiratory syncytial virus, adenovirus, influenza, or parainfluenza,
and confirmed by fluorescent antibody (FA) or real-time polymerase chain reaction (RT-
PCR) assay of nasopharyngeal aspirates.
Results
Of 14,044 patients, 37.7% (5290) had FA- or RT-PCR-confirmed samples that identified
influenza in 2.8% (394/14,044; 91.4% [360] influenza A, 8.6% [34] influenza B) of cases.
Influenza frequency followed a seasonal epidemic pattern (May–July, the lowest average
temperature months). The median age of cases was 12 months (interquartile range: 6–21
months); 56.1% (221/394) of cases were male. Consolidated pneumonia was the most fre-
quent clinical presentation (56.9%; 224/394). Roughly half (49.7%; 196/394) of all cases
had previous respiratory admissions; 9.4% (37/394) were re-admissions; 61.5% (241/392)
had comorbidities; 26.2% (102/389) had complications; 7.8% (30/384) had nosocomial
infections. The average case fatality rate was 2.1% (8/389). Chronic neurologic disease was
significantly higher in influenza B cases compared to influenza A cases (p = 0.030). The
independent predictors for influenza were: age6 months, odds ratio (OR): 1.88 (95% con-
fidence interval [CI]: 1.44–2.45); p<0.001; presence of chronic neurologic disease, OR: 1.48
(95% CI: 1.01–2.17); p = 0.041; previous respiratory admissions, OR: 1.71 (95% CI: 1.36–
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2.14); p<0.001; re-admissions, OR: 1.71 (95% CI: 1.17–2.51); p = 0.006; clinical pneumo-
nia, OR: 1.50 (95% CI: 1.21–1.87); p<0.001; immunodeficiency, OR: 1.87 (95% CI: 1.15–
3.05); p = 0.011; cystic fibrosis, OR: 4.42 (95% CI: 1.29–15.14); p = 0.018.
Conclusion
Influenza showed an epidemic seasonal pattern (May–July), with higher risk in children6
months, or with pneumonia, previous respiratory admissions, or certain comorbidities.
Introduction
Respiratory tract infections are one of the main causes of medical visits in pediatrics [1,2], con-
stituting a major public health problem. Viruses are the most commonly implicated agents in
acute lower respiratory infection (ALRI) in children <5 years old [3], the most important
being respiratory syncytial virus (RSV), influenza A and B, adenovirus (AV), and parainflu-
enza 1, 2, and 3; however, other pathogens such as human metapneumovirus and rhinovirus
have more recently been recognized as causes of ALRI [3]. Of these, influenza has distinctive
characteristics regarding its epidemiologic, genetic, and antigenic properties, as well as its
impact on the general population. Influenza remains an important infectious disease across
the globe and causes considerable morbidity and mortality [1].
Influenza has an estimated annual attack rate of 5–10% in adults and 20–30% in children,
with reports of severe illness in 3–5 million cases and almost half a million deaths globally [1].
It is estimated that, annually, 60% of children <1 year old and 50% of children <5 years old
experience an acute respiratory infection of some type, including obstructive bronchitis and
pneumonia [1,2]. Modeling studies suggest that children <2 years old have high rates of hospi-
talization that are attributable to influenza [1,4,5]. Though seasonal influenza can affect any
population, children aged <2 years have the highest risk of complications [1]. Estimation of
the true influenza burden remains a challenge. The data collected through influenza surveil-
lance and case-finding represent only a fraction of those infected with influenza because not
all of those infected with influenza will seek a medical diagnosis and be reported through their
country’s influenza surveillance program [6]. A central feature of influenza is its antigenic vari-
ability, which is the result of two main mechanisms: antigenic drift and antigenic shift. The lat-
ter occurs only with the influenza A virus, giving rise to viral strains unknown to the human
immune system and potentially resulting in pandemics [7].
At the Ricardo Gutie´rrez Children’s Hospital in Buenos Aires, Argentina, there has been
active epidemiologic surveillance of respiratory viruses in hospitalized patients with ALRI
since 2000. This program allows observation of the distribution of viral agents in hospitalized
patients, detection of outbreaks, and establishment of control measures, as well as a network of
adequate containment. Active epidemiologic surveillance is an important tool to assess the
impact of respiratory viruses in a pediatric population. Influenza mortality and morbidity in
Latin America and the Caribbean is possibly underreported and thus information is not read-
ily available. In Latin America and the Caribbean, most reported data come from a diagnosis
of influenza-like illness and the true burden of influenza remains obscure because specific
diagnostic tools to confirm etiology are often not used [8]. In Argentina, respiratory infections
are among the five leading causes of death in children <5 years old [2]. The aims of this study
were to describe the clinical and epidemiologic pattern of influenza and factors associated with
influenza and to compare the characteristics of influenza A and B cases.
Influenza in hospitalized children in Argentina
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Materials and methods
A prospective, epidemiologic, cross-sectional study was conducted in accordance with the
World Medical Association Declaration of Helsinki International Code of Ethics for experi-
ments involving humans; the privacy rights of patients were always observed. Patient’s in-
formed consent is not applicable in this study because the data were obtained from a routine
epidemiological surveillance activity included in the framework of Argentinian Law 15465/60.
The study was approved by the Ethics and Research Committees of the Ricardo Gutie´rrez
Children’s Hospital. This study will not affect human rights, nor will it cause damage to the
environment, animals and/or future generations. All patients admitted for ALRI acquired in
the community were detected through the active Epidemiological Surveillance Program at the
Ricardo Gutie´rrez Children’s Hospital, Buenos Aires, between 2000 and 2015. The study
included all children (18 years of age) who were hospitalized for ALRI with bronchiolitis or
pneumonia. The definition of pneumonia in this study was acute infection of the pulmonary
parenchyma with clinical signs of alveolar occupation. All admitted children with ALRI un-
derwent viral testing for diagnosis. Data were collected with a specific case-reporting form,
including date of admission, demographics (e.g., age, sex, the patient’s city of residence), clini-
cal presentation (bronchiolitis, pneumonia), previous hospitalizations related to respiratory
disease, readmission for the same episode, comorbidities, history of close contact with any
acute respiratory disease of probable viral cause (runny nose, cough, and/or fever), neonatal
respiratory pathology, complications during hospitalization and patient’s course in hospital
(discharge, transfer to another center, death), treatment, and length of stay. Comorbidities
noted included chronic or recurrent respiratory disease, malnourishment, congenital heart
disease, genetic or neurologic diseases, and immunodeficiency.
Regarding chronic or recurrent respiratory disease, the presence of any of the following
conditions was recorded: recurrent obstructive bronchitis or asthma, gastroesophageal reflux
disease, cystic fibrosis, bronchopulmonary dysplasia, recurrent laryngitis, and pneumonia;
recurrent obstructive bronchitis was defined as the occurrence of two or more broncho-
obstructive episodes. As complications, nosocomial infections, sepsis, persistent atelectasis,
pneumothorax, pleural effusion, bullae, abscesses, ear infections, diarrhea, convulsions, and
meningitis were considered. Nosocomial infection was defined as an exacerbation of respira-
tory symptoms not present at admission (even if incubating), presenting in patients hospital-
ized for48 hours, expressed as fever, increased oxygen requirement, or changes to radiologic
pattern.
Diagnostic methods
The clinical and radiologic diagnosis of bronchiolitis and pneumonia was conducted in accor-
dance with the guidelines of the Argentinian Society of Pediatrics [9]. Virologic diagnosis was
performed by indirect fluorescent antibody of nasopharyngeal aspirates in all cases. Real-time
polymerase chain reaction (RT-PCR) assay became available from 2009 and was used in addi-
tion to the indirect fluorescent antibody method for detection of RSV, AV, influenza A and B,
and parainfluenza virus. For all diagnoses, commercially available methods were used.
Statistical analysis
Epi Info™ version 7 (US Centers of Disease Control and Prevention, Atlanta, GA, USA) was
used for data analysis. The categorical variables were analyzed using the χ2 test with Yates cor-
rection. We used the Wilcoxon test for comparing median age. The measure of association
used was the odds ratio (OR) with a confidence interval (CI) of 95%. A bivariate analysis was
performed first to identify the significant association. Following this, a multivariate analysis
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was carried out to establish independent predictors using logistic regression model of SPSS
software version 15.0 (SPSS Inc., Chicago, IL, USA). The following variables were included in
the model: age6 months, chronic neurologic disease, previous admissions for respiratory
causes, readmissions, presentation with clinical pneumonia, immunodeficiency, cystic fibrosis,
congenital heart disease, and previous admissions for respiratory causes. A probability of less
than 0.05 was considered significant.
Results
A total of 14,044 patients were included, 37.7% (5290) of whom had positive samples; influenza
represented 2.8% (394/14,044); of these, 91.4% (360/394) had influenza A and 8.6% (34/394)
had influenza B. The influenza activity data (Fig 1) showed a seasonal epidemic pattern from
Fig 1. Seasonal distribution of confirmed influenza cases in hospitalized children in Buenos Aires, Argentina, 2000–2015 (n = 394). aMoving average trend line,
period = 2.
https://doi.org/10.1371/journal.pone.0195135.g001
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May to July (interquartile range [IQR] of epidemiologic weeks [EW] of viral activity: 24–29),
with peaks of major activity matching low temperatures and higher humidity. Influenza inci-
dence remained high throughout the winter until spring. The peaks were observed between
EW 25–26 (June), except during 2003, which showed earlier peaks from EW 21 (May). No
influenza cases were recorded in 2002.
The annual distribution of respiratory viruses varied somewhat over the past 16 years; how-
ever, RSV was consistently the most frequently reported pathogen (Fig 2). The median age of
influenza cases was 12 months (IQR: 6–21 months) and 56.1% were male (Table 1). Consolidated
pneumonia was the most frequent clinical presentation (56.9%). Comorbidities were found in
61.5% (241/392) of patients. Complications were detected in 26.2% (102/389) of patients. Each
patient may have had>1 comorbidity or complication. Comparing influenza A and B, chronic
neurologic disease was significantly higher in influenza B cases (p = 0.030) (Table 1).
While comparing influenza cases (influenza A and B) against the non-influenza ALRI cases
(RSV, parainfluenza virus, AV), the following were independent predictors for influenza infec-
tion: age6 months (compared with<6 months), OR: 1.88 (95% CI: 1.44–2.45); p<0.001
Fig 2. Annual distribution of confirmed viral pathogens in nasopharyngeal aspirates of hospitalized children in Buenos Aires, Argentina, 2001–2015 (n = 5290).
AV, adenovirus; PIV, parainfluenza virus; RSV, respiratory syncytial virus.
https://doi.org/10.1371/journal.pone.0195135.g002
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(Table 2); presence of chronic neurologic disease, OR: 1.48 (95% CI: 1.01–2.17); p = 0.041; pre-
vious admissions for respiratory causes, OR: 1.71 (95% CI: 1.36–2.14); p<0.001; readmissions,
OR: 1.71 (95% CI: 1.17–2.51); p = 0.006; presentation with clinical pneumonia, OR: 1.50 (95%
CI: 1.21–1.87); p<0.001; immunodeficiency, OR: 1.87 (95% CI: 1.15–3.05); p = 0.011; cystic
fibrosis, OR: 4.42 (95% CI: 1.29–15.14); p = 0.018.
Discussion
The present study shows that, in Argentina, influenza incidence in hospitalized children was
higher from winter through spring. Peaks of incidence in June correspond to periods of low
Table 1. Clinical and demographic characteristics of hospitalized children with confirmed influenza A and B in Buenos Aires, Argentina, 2000–2015 (n = 394).
Confirmed influenza (A: n = 360; B, n = 34) Influenza A n (%) Influenza B n (%) OR (95% CI) p value
Sex (male) 200 (55.6) 21 (61.7) 0.77 (0.37–1.59) 0.485
Median age: 1 year (IQR: 6–21 months) 12 (6–21) 17.5 (8–35) 0.082
<3 months (vs 3 months) 34 (9.4) 0 (0) Undefined –
<6 months (vs 6 months) 80 (22.2) 5 (14.7) 1.65 (0.62–4.42) 0.309
<12 months (vs12 months) 174 (48.3) 13 (38.2) 1.51 (0.73–3.11) 0.260
<24 months (vs24 months) 278 (77.2) 24 (70.6) 1.41 (0.64–3.07) 0.382
>24 months to5 years (vs >5 years) 53 (14.7) 6 (17.6) 0.80 (0.31–2.03) 0.648
Prematurity (A:358; B:34) 71 (19.8) 3 (8.8) 2.55 (0.75–8.60) 0.117
Neonatal respiratory pathology (A:358; B:34) 67 (18.7) 5 (14.7) 1.33 (0.49–3.57) 0.564
Immunodeficiency (A:357; B:34) 18 (5.0) 4 (11.8) 0.39 (0.12–1.25) 0.104
Malnourished (A:357; B:33) 30 (8.4) 6 (18.2) 0.41 (0.15–1.08) 0.063
Previous admissions for respiratory causes (A:357; B:34) 177 (49.6) 19 (55.9) 0.77 (0.38–1.57) 0.483
Comorbiditiesa A: n = 219 / B: n = 22
Recurrent obstructive bronchitis 159 (72.6) 15 (68.2) 1.24 (0.48–3.18) 0.659
Chronic neurologic disease 31 (14.2) 7 (31.8) 0.35 (0.13–0.93) 0.030
Congenital heart disease 20 (9.1) 3 (13.6) 0.63 (0.17–2.34) 0.493
Complicationsb A: n = 91 / B: n = 11
Respiratory distress 31 (34.1) 5 (45.4) 0.62 (0.17–2.19) 0.457
Acute otitis media 23 (25.3) 2 (18.2) 1.52 (0.30–7.56) 0.607
Atelectasis 11 (12.1) 2 (18.2) 0.62 (0.12–3.24) 0.568
Sepsis 14 (15.4) 2 (18.2) 0.82 (0.16–4.19) 0.810
A, influenza A; B, influenza B; CI, confidence interval; IQR, interquartile range; OR, odds ratio.
a Patients may have had >1 comorbidity.
b Complication percentage calculations are based on n = 102 patients with complications.
https://doi.org/10.1371/journal.pone.0195135.t001
Table 2. Multivariate analysis of the probability of influenza diagnosis among all confirmed viral pathogens in nasopharyngeal aspirates of hospitalized children in
Buenos Aires, Argentina, 2001–2015 (n = 5290).
Independent predictors Influenza (n = 394) Other pathogen (n = 4896) Adjusted OR 95% CI p value
Age6 months 78.4% (309) 58.7% (2875) 1.88 1.44–2.45 <0.001
Chronic neurologic disease 9.6% (38) 4.4% (218) 1.48 1.01–2.17 0.04
Previous admissions for respiratory causes 49.7% (196) 29.5% (1444) 1.71 1.36–2.14 <0.001
Re-admission for the same episode 9.4% (37) 4.3% (213) 1.71 1.17–2.51 0.006
Pneumonia clinical presentation 56.9% (224) 40.2% (1968) 1.50 1.21–1.87 <0.001
Immunodeficiency 5.6% (22) 2.1% (103) 1.87 1.15–3.05 0.011
CI, confidence interval; OR, odds ratio.
https://doi.org/10.1371/journal.pone.0195135.t002
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temperature and high humidity, consistent with the seasonal influenza epidemiologic pattern
in temperate regions [10]. However, earlier studies have associated peak influenza incidence
with low temperature and low indoor humidity in temperate regions [11], and with relatively
higher temperatures and higher humidity in tropical regions [11–14]. Thus, further studies are
needed to understand the association of influenza epidemic patterns with low temperature and
high humidity. We show that, although the annual distribution of respiratory viruses has var-
ied over time, RSV has remained the most frequently reported pathogen. This is in line with
our previous publication on clinical and epidemiologic patterns of RSV in pediatric pop-
ulations [15]. The high peak of influenza in 2009 reflects the occurrence of the swine flu
pandemic.
The present study found that 49.7% of patients with influenza reported comorbidities and
26.2% of patients had medical complications. Consolidated pneumonia was a predominant
clinical characteristic among patients with confirmed influenza, and this has recently been
documented elsewhere [16]. Patients with previous hospitalization for respiratory causes were
more prone to be affected by seasonal influenza. No significant association was found when
comparing cases of influenza A and B infection. Studies on pediatric and adult populations
have compared demographic and clinical features of patients with influenza A versus influenza
B, and have generally found few differences [17–19]. This study is based on an active epidemi-
ologic surveillance carried out since 2000 in the Ricardo Gutie´rrez Children’s Hospital, which
is a tertiary center, and a national and international reference pediatric hospital serving the
metropolitan area of Buenos Aires, Argentina. The value of the extensive experience gained
by the same surveillance team using the same criteria over 16 years is demonstrated in the
strength of our data. On the other hand, the Virology Laboratory is a national center of refer-
ence for diagnosis. To the best of our knowledge, this is the largest report of data (more than
14,000 specimens) from children hospitalized with ALRI in Argentina, documenting the clini-
cal and epidemiologic pattern of seasonal influenza between 2000 and 2015. Marcone et al.
have recently reported similar outcomes on the incidence of viral respiratory infection in a
prospective cohort study including inpatient and outpatient Argentinian children5 years
old [20]. However, that study reported the respiratory viral incidence of only ~1800 patients
between 2008 and 2010. Therefore, the current study has provided a broader estimation of
influenza burden and seasonal influenza epidemiologic patterns in Argentinian children hos-
pitalized with ALRI.
This study has the limitation of being a hospital-based study, and it is not possible to infer
results for the general population. We also did not collect data of other sociodemographic vari-
ables that might influence the results, such as socioeconomic status, housing conditions, over-
crowding, attendance at preschool or kindergarten, or number and age of cohabitants.
Conclusion
Influenza in hospitalized children in Argentina showed a seasonal epidemic pattern (May–
July) and mostly affected children6 months old, as well as those who had pneumonia, previ-
ous admissions for respiratory causes, and certain comorbidities.
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